The 2nd International Conference on Drug Discovery and Development (IC3D) 2026 is a scientific conference organised jointly by the Malaysian Society of Pharmaceutical Technology (MSPT) in collaboration with the School of Pharmaceutical Sciences, Universiti Sains Malaysia, UniKL and Monash University Malaysia. It aims to bring together scientists, researchers, and clinicians to share their latest research and insights on drug discovery and development.

This year's theme, "Transforming Therapeutics: Nanomedicine, Drug Safety and Personalised Therapies for Global Health," highlights the urgent need to move beyond promising laboratory breakthroughs toward trusted, effective and equitable therapies. By bringing together advances in nanomedicine with robust frameworks for drug safety, and strategies for personalised therapies, the conference will explore how next-generation medicines can be designed to deliver the right drug, to the right patient, at the right time—while maintaining high standards of safety throughout development and real-world use.